Knowledge Organization (journal)

ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 28, 2024
Oncology, Health, FDA, Clinical Trials, Pharmaceutical, Biotechnology, Diagnosis, De novo, PIN, Obesity, MRI, Syndrome, Metabolism, KCH, Knowledge Organization (journal), International, National Health Service, NHS, Research, Radiology, MASH, Trial of the century, International Classification of Diseases, Hepatology, World Health Organization, Data collection, Prediabetes, NDRA, Liver, Type 2 diabetes, Liver disease, Marketing, NAFLD, Endocrinology, Video game

ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.

Key Points: 
  • ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today reports financial results for the three months and year ended December 31, 2023 and provides a business update.
  • Highlights from the fourth quarter of 2023 and recent weeks include:
    Installed first TAEUS system in the UK at King’s College Hospital for clinical evaluation.
  • In the third quarter of 2023, ENDRA submitted a De Novo request for its TAEUS liver system to the FDA.
  • In the fourth quarter of 2023, the FDA issued an Additional Information (AI) request to ENDRA.

New ICD-10-CM Code by the World Health Organization Paves the Way for Improved NAFLD Diagnostics Including ENDRA Life Sciences’ TAEUS System

Retrieved on: 
Wednesday, February 21, 2024
FDA, Health, Diabetes, Surgery, Health Insurance, Pharmaceutical, Therapy, CE, American Diabetes Association, NAFLD, Endocrinology, T2D, Research, Medicine, Person, CMS, Non-alcoholic fatty liver disease, Liver disease, NDRA, Prediabetes, Obesity, Cardiovascular disease, Food, ALT, De novo, Global health, Weill Cornell Medicine, Risk, Hepatology, Cirrhosis, European, Prevalence, Ultrasound, World Health Organization, Medicare, Type 2 diabetes, Metabolic syndrome, Patient, Fibrosis, Primary care, Fatty liver disease, NASH, Diagnosis, Knowledge Organization (journal), WHO, International Classification of Diseases, Dietary supplement

The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), is a global coding system used to indicate a diagnosis for reimbursement purposes.

Key Points: 
  • The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM), is a global coding system used to indicate a diagnosis for reimbursement purposes.
  • These codes are issued by the World Health Organization (WHO) and are used to show payers why a particular service was medically necessary.
  • The inclusion of NAFLD under the ICD-10 K76.0 code facilitates standardized billing for its diagnosis.
  • "This positive development is testament to the growing awareness of liver health and the intensifying need for effective diagnostic solutions.

Voya Financial expands its workplace benefits offerings with new supplemental health insurance solution

Retrieved on: 
Wednesday, February 21, 2024
Technology, Professional Services, Health, Health Technology, Health Insurance, Asset Management, Apps, Applications, Software, Insurance, Human Resources, Finance, Diabetes, Anxiety, Emergency, Mental health, Workplace, Voya Financial, Bipolar disorder, Concussion, Asthma, ICD-10, Stroke, Family, DSM-IV codes, Epilepsy, International Classification of Diseases, Knowledge Organization (journal), Ageing, Research, Protection, Health insurance

Voya Financial, Inc. (NYSE: VOYA), announced today that it continues to enhance its growing portfolio of workplace benefits by offering an innovative, technology-enabled solution to help employees ease the burden of out-of-pocket medical costs.

Key Points: 
  • Voya Financial, Inc. (NYSE: VOYA), announced today that it continues to enhance its growing portfolio of workplace benefits by offering an innovative, technology-enabled solution to help employees ease the burden of out-of-pocket medical costs.
  • Voya Protect, a new Group Limited Benefit Insurance powered by the insurance technology company Ansel Health, is a supplemental health offering that is designed to pay benefits quickly and easily when covered conditions are diagnosed.
  • And, while many employers have made changes to their benefit lineups to help support their employees, the reality is that workplace benefits are complex,” explained Nate Black, vice president, Health Solutions Product at Voya Financial.
  • Voya Protect is the latest example of how Voya is focused on providing innovative solutions and capabilities to help employers and their employees optimize their workplace benefits and savings needs.

AI Identifies Non-smokers at High Risk for Lung Cancer

Retrieved on: 
Wednesday, November 22, 2023
Deep learning, Medicine, Lung, Health, RSNA, Smoker, Research, MGH, National academy, Incidence, American Cancer Society, National Comprehensive Cancer Network, Risk, Disease, Hospital, Mortality, Serum, B.A, Patient, Respiratory tract infection, Tobacco, Smoke, Artificial intelligence, Knowledge Organization (journal), Non-Smokers' Rights Association, USPSTF, Prostate, Lung cancer screening, Lung cancer, Newsroom, Harvard Medical School, Diagnosis, CIRC, Massachusetts General Hospital, Medicare, Chronic obstructive pulmonary disease, Biomarker, Cancer, Society, Radiology, Radiation, Education, Risk management, Medical imaging, Boston

The American Cancer Society estimates about 238,340 new cases of lung cancer in the United States this year and 127,070 lung cancer deaths.

Key Points: 
  • The American Cancer Society estimates about 238,340 new cases of lung cancer in the United States this year and 127,070 lung cancer deaths.
  • Existing lung cancer risk scores require information that is not readily available for most individuals, such as family history of lung cancer, pulmonary function testing or serum biomarkers.
  • For the study, CIRC researchers set out to improve lung cancer risk prediction in never-smokers by testing whether a deep learning model could identify never-smokers at high risk for lung cancer, based on their chest X-rays from the electronic medical record.
  • The high-risk group well exceeded the 1.3% six-year risk threshold where lung cancer screening CT is recommended by National Comprehensive Cancer Network guidelines.

The MOG Project, Pediatric Neurologist Secure CDC Approval to Adopt ICD-10 Code for Rare Disease MOGAD

Retrieved on: 
Monday, October 2, 2023
Insurance, Optic neuritis, General assembly, Disease, United Nations, Glycoprotein, CHLA, Neuroimmunology, ICD, Lou Ruvo Center for Brain Health, Knowledge Organization (journal), United Nations General Assembly, Centers for Disease Control and Prevention, Research, Brain, Children's Hospital, Multiple sclerosis, CDC, MOGAD, MD, Patient, Physician, Children's Hospital Los Angeles, Immune system, Optic nerve, Stockholm Environment Institute US Center, Transverse myelitis, Diagnosis, Knowledge, Neuromyelitis optica spectrum disorder, Barrow Neurological Institute, International Classification of Diseases, Video game–related health problems, FDA, Acute disseminated encephalomyelitis, WHO, World Health Organization, Medical device

OLNEY, Md., Oct. 2, 2023 /PRNewswire-PRWeb/ -- The MOG Project, a nonprofit organization committed to supporting the research and treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease (MOGAD) announced that its Executive Director Julia Lefelar, with support from The MOG Project Executive Board and Children's Hospital Los Angeles (CHLA) Pediatric Neurologist Jonathan Santoro, MD, secured approval to have the US Centers for Disease Control and Prevention (CDC) create an ICD-10 code for MOGAD. As of October 1, 2023, an official code for MOGAD is included in the 10th edition of the International Classification of Diseases (ICD) and Related Health Problems, which is relied upon by physicians and insurance providers to classify diagnoses and advise treatment.

Key Points: 
  • Without a CDC code, MOGAD patients had previously been grouped in with patients with similar diseases like neuromyelitis optica spectrum disorder, optic neuritis, acute disseminated encephalomyelitis, transverse myelitis and even multiple sclerosis.
  • "For the MOGAD community, this CDC code is more than a win for better health outcomes and fewer insurance delays, it gives our rare disease an identity and legitimizes it."
  • "The addition of a MOGAD specific ICD-10 code allows patients to better access the therapies that they need to treat their disease," said Santoro.
  • "Further, it allows for disease monitoring across the country, which will increase knowledge and research on this rare neuroimmunology disorder."

Rhythm Pharmaceuticals Announces New ICD-10 Diagnosis Code Established for Bardet-Biedl Syndrome

Retrieved on: 
Wednesday, September 6, 2023
Polyphagia, Obesity, International Classification of Diseases, Prevalence, Bardet–Biedl syndrome, Deficit spending, Visual impairment, Knowledge Organization (journal), Brain, CDC, BBS, HIV disease progression rates, Patient, Physician, Syndrome, Korea Disease Control and Prevention Agency, Hypothalamus, MC4R, Diagnosis, Hunger, News, Hypogonadism, Polydactyly, Disease, Pharmaceutical industry, Nursing

The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023.

Key Points: 
  • The new code, Q87.83 Bardet-Biedl syndrome (BBS), takes effect Oct. 1, 2023.
  • “Finding and connecting patients, families and physicians across the country has been extremely challenging because of the lack of a dedicated ICD-10 code as patients with BBS are lumped in with many other genetic syndromes,” said Tim Ogden, President of the BBS Foundation.
  • “We believe this new disease specific ICD-10 code marks an important advance for the care of patients with BBS,” said Jennifer Chien, Rhythm Executive Vice President and Head of North America.
  • People living with BBS also may experience cognitive impairment, polydactyly, renal dysfunction, hypogonadism, and visual impairment.

Empowering Tomorrow's Healthcare Leaders: USAHS Sponsors 6th Annual U.S. Open Adaptive Surfing Championship

Retrieved on: 
Wednesday, August 30, 2023
University of St. Augustine for Health Sciences, University, Education, Employment, Knowledge Organization (journal), Para, Assistant, Occupational therapy, Athlete, International Classification of Functioning, Disability and Health, Student, Outline of health sciences, USAHS, Oceanside Pier, Empowerment, Nursing, Entertainment

OCEANSIDE, Calif., Aug. 30, 2023 /PRNewswire/ -- The anticipation is building as the 6th Annual U.S. Open Adaptive Surfing Championship approaches, slated to take place from September 6th to 10th at the iconic Oceanside Pier in Oceanside, California. Proudly sponsored by the University of St. Augustine for Health Sciences (USAHS) for the fourth consecutive year, this event not only showcases the incredible athleticism of adaptive surfers from around the world but also highlights the university's commitment to community support and hands-on education.

Key Points: 
  • OCEANSIDE, Calif., Aug. 30, 2023 /PRNewswire/ -- The anticipation is building as the 6th Annual U.S. Open Adaptive Surfing Championship approaches, slated to take place from September 6th to 10th at the iconic Oceanside Pier in Oceanside, California.
  • "The University of St. Augustine for Health Sciences is thrilled to once again be the title sponsor of the U.S. Open Adaptive Surfing Championship," said Dr. Mo Johnson, Assistant Professor of the Occupational Therapy Program at USAHS and Head of the International Classification for Para Surfing.
  • With over 100 athletes from more than 17 countries participating, the U.S. Open Adaptive Surfing Championship has evolved into an international gathering of champions.
  • For more information about the 6th Annual U.S. Open Adaptive Surfing Championship and the University of St. Augustine for Health Sciences, please visit https://usopenadaptivesurfingchampionships.com/ .

LSUS Alumni Create Medical Coding Chatbot to Reduce Time, Improve Accuracy

Retrieved on: 
Tuesday, August 22, 2023
Heart, Insurance, Medicine, Disease, Health, LSUS, Learning curve, Cancer, ICD, Intelligence, Knowledge Organization (journal), Research, Discord, Student, Machine learning, Microsoft Excel, CPA, AI, Patient, Social media, International Classification of Diseases, Software, Medical device, Nursing, Customer service

SHREVEPORT, La., Aug. 22, 2023 /PRNewswire/ -- LSUS alumni developed an innovative medical coding chatbot that is designed to reduce time and improve accuracy of medical coding.

Key Points: 
  • SHREVEPORT, La., Aug. 22, 2023 /PRNewswire/ -- LSUS alumni developed an innovative medical coding chatbot that is designed to reduce time and improve accuracy of medical coding.
  • Medical coders typically endure months of training, but the medical coding chatbot could lessen that learning curve and better prepare coders.
  • This free platform could introduce the medical coding chatbot to a wider audience than other paid platforms like Slack.
  • Medical professionals wanting to test the medical coding chatbot: https://discord.gg/x5BXTPqG7U

Insomnia Epidemiology Forecast - 2023-2032: Diagnoses Set to Increase in the Coming Years - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 16, 2023
Health, Other Health, Epidemiology, EMA, American Academy of Sleep Medicine, DMS, Sleep, Research, United Kingdom, Actigraphy, Central sleep apnea, Arousal, ISI, DSM-IV codes, Knowledge Organization (journal), PSQI, Risk, Prevalence, Fatigue, Hormone, DSM, Pittsburgh Sleep Quality Index, Patient, American Academy, Diagnosis, REM, Classification, Obstructive sleep apnea, Polysomnography, EU4, Somatization disorder, Thermoregulation, Wakefulness, Sedation, DIS, Sleep-related breathing disorder, Vaccine, Pharmaceutical industry, Nursing, Insomnia

Whereas DSM-V defines Insomnia as dissatisfaction with sleep quantity or quality, often associated with either difficulty initiating sleep or difficulty maintaining sleep.

Key Points: 
  • Whereas DSM-V defines Insomnia as dissatisfaction with sleep quantity or quality, often associated with either difficulty initiating sleep or difficulty maintaining sleep.
  • Recently, these categories were changed American Academy of Sleep Medicine categorizes insomnia into short-term insomnia, chronic insomnia, and other insomnia.
  • Other previously used subtypes now under chronic insomnia included paradoxical insomnia, idiopathic insomnia, psychophysiological insomnia, and inadequate sleep hygiene, among others.
  • The report provides the segmentation of the disease epidemiology for the 7MM, Total Diagnosed Prevalent Cases of Insomnia, Type-specific CDases of Insomnia, Gender-specific Cases of Insomnia, and Age-specific Cases of Insomnia.

CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Institutions Leading Research to Advance the Future of Hearing Health and Deaf Studies

Retrieved on: 
Tuesday, January 10, 2023
Linda, Deafblindness, Grant (money), FEC, Infant, Gallaudet University, University, Ball State University, MacEwan University, ASL, Fatigue, Dizziness, Knowledge Organization (journal), Hearing loss, Quality of life, American Sign Language, University of Alberta, Risk, Research, Social determinants of health, Hearing, The Fall Risk, Disability, Magic: The Gathering core sets, 1993–2007, Innovation, CHS, Ball, Pharmaceutical industry, Medical device, Deafness, Western University

TORONTO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- CHS Global Partnerships for Research & Innovation, a non-profit organization and strategic global leader in the advancement of research and innovation that improves the quality of life for Deaf and hard of hearing individuals, is excited to announce that it has awarded its first four research grants – totalling $400,000 - to institutions leading research that will break down barriers to participation for Deaf and hard of hearing individuals and their families.

Key Points: 
  • To learn more, click here .
  • We are proud to offer research grants that support the brightest researchers and innovators in the world in their quest to reimagine the future of hearing health and Deaf studies,” says Julia N. Dumanian, President & Chief Executive Officer of Canadian Hearing Services.
  • Tamaki's research has strong potential to improve the quality of life for older Deaf adults experiencing balance problems and who are at risk for falls.
  • I wholeheartedly congratulate Dr. Tamaki on this award that will allow this important research to reduce health inequities and have a positive impact on our communities.”